High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.7M
$1,682,644
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| RLAY |
Relay Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-03-09 | $178,233 | S | Form 4 |
| RLAY |
Relay Therapeutics, Inc.
|
President
Sell to Cover
|
2026-01-28 | $22,697 | S | Form 4 |
| RLAY |
Relay Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-01-28 | $14,323 | S | Form 4 |
|
RLAY
S
Relay Therapeutics, Inc.
Rahmer Peter
• Officer • See remarks
Sell to Cover
2026-01-28
$11,441
|
||||||
| RLAY |
Relay Therapeutics, Inc.
|
Officer • See remarks
Sell to Cover
|
2026-01-28 | $11,441 | S | Form 4 |
| RLAY |
Relay Therapeutics, Inc.
|
President
Sell to Cover
|
2026-01-27 | $143,980 | S | Form 4 |
| RLAY |
Relay Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-01-27 | $105,308 | S | Form 4 |
|
RLAY
S
Relay Therapeutics, Inc.
Rahmer Peter
• Officer • See remarks
Sell to Cover
2026-01-27
$89,032
|
||||||
| RLAY |
Relay Therapeutics, Inc.
|
Officer • See remarks
Sell to Cover
|
2026-01-27 | $89,032 | S | Form 4 |
| RLAY |
Relay Therapeutics, Inc.
|
CEO
Sell to Cover
|
2025-11-03 | $434,511 | S | Form 4 |
|
RLAY
S
Relay Therapeutics, Inc.
Rahmer Peter
• Officer • See remarks
Discretionary Sell
2025-10-29
$160,455
|
||||||
| RLAY |
Relay Therapeutics, Inc.
|
Officer • See remarks
Discretionary Sell
|
2025-10-29 | $160,455 | S | Form 4 |
| RLAY |
Relay Therapeutics, Inc.
|
President
Sell to Cover
|
2025-10-28 | $225,239 | S | Form 4 |
| RLAY |
Relay Therapeutics, Inc.
|
CFO
Sell to Cover
|
2025-10-28 | $157,931 | S | Form 4 |
|
RLAY
S
Relay Therapeutics, Inc.
Rahmer Peter
• Officer • See remarks
Sell to Cover
2025-10-28
$139,494
|
||||||
| RLAY |
Relay Therapeutics, Inc.
|
Officer • See remarks
Sell to Cover
|
2025-10-28 | $139,494 | S | Form 4 |